Carnelian
Sector: Hospital • Location: Colombia
Source: IFC Project Disclosures
The project consists of an equity investment of up to USD 90 million into the Unimed Pharmaceuticals Limited and Sofgen Pharmaceuticals LLC (the “Group”), a Life Sciences group of companies with operations across Latin America, to support its expansion in the region. The Group’s key subsidiary is Procaps SA based in Colombia.
- Status
- Prospective
- Sector
- Hospital
- Location
- Colombia
- Updated
- 19 Nov 2026
- Source
- IFC Project Disclosures
ConstructChat
Ask ConstructChat about Carnelian
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | active |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | The project consists of an equity investment of up to USD 90 million into the Unimed Pharmaceuticals Limited and Sofgen Pharmaceuticals LLC (the “Group”), a Life Sciences group of companies with operations across Latin America, to support its expansion in the region. The Group’s key subsidiary is Procaps SA based in Colombia. |
Original sector | G-FA - Pharmaceuticals and Medicine |
Location
Country | Colombia |
Source
Source | IFC Project Disclosures |
URL |
More Details
Record type | Project |
Sector | Hospital |
Article published date | 2026-09-09 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
